Historically, a solitary pulmonary metastasis of prostate cancer was considered as metastatic or disseminated disease and could only be treated systemically. However, some patients may benefit from surgical metastasectomy of a solitary pulmonary metastasis. We present an uncommon case of resection of a solitary pulmonary metastasis of prostate cancer after previous radical prostatectomy, resulting in undetectable prostate specific antigen.
Introduction
Cancer-free survival benefit has been reported after surgery for a solitary pulmonary metastasis for colonic [1] , renal cell [2] and breast cancer [3] . Visceral metastasis of prostate cancer (PCa) is regarded as only treatable by systemic therapy [4] . Only a few case reports on resection of a solitary pulmonary metastasis after previous radical prostatectomy have been published [5] [6] [7] [8] [9] [10] [11] .
Case Report
A 82-year-old man underwent a non-nerve sparing radical prostatectomy without pelvic lymph node dissection 12 years earlier for a pT3a Gleason 6 adenocarcinoma with an initial prostate specific antigen (PSA) of 10.1 µg/l. Surgical margins were negative. The postoperative PSA was 1.6 µg/l and adjuvant radiotherapy (66 Gy) was performed together with androgen deprivation therapy. The PSA was afterwards undetectable during 2 years. Because of biochemical recurrence bicalutamide was associated but PSA continued to rise and the PCa was considered as castrate refractory.
Nine years postoperatively, the patient was admitted to the gastroenterology department for hematochezia. An incidental lesion in the right lower lung lobe was found on chest radiograph. CT scan showed a nodular lesion of 2 cm in the right lower lobe with hypercaptation on PET scan without mediastinal adenopathies or distant metastases ( fig. 1, 2) . A bronchoscopy with bronchial brushing was performed next, which showed atypical glandular epithelial cell, suspicious for adenocarcinoma.
The case was discussed in a multidisciplinary oncology meeting and local therapy with surgical excision was suggested. The patient refused however and preferred follow-up. The PSA had risen in the meantime to 3.32 µg/l. A CT scan, performed 3 months later, showed a slight increase in volume of the known lesion and this time the patient agreed with surgery. Resection of the nodular lesion was performed by thoracotomy with lobectomy. Immunohistochemical staining of PSA on the resection specimen was positive, confirming the diagnosis of a single pulmonary metastasis of PCa. Postoperatively, the PSA lowered to undetectable levels (< 0.03 µg/l). Consequently, the hormonal therapy was interrupted and 1 year later, the PSA remained under the detection level. 
Discussion
PCa generally metastasizes to bone and regional lymph nodes and less frequent to lung, liver and brain [12] [13] [14] . Metastatic PCa is believed to benefit only from systemic therapy, however increasing evidence of the benefit of metastasectomy is found [14, 15] . An isolated pulmonary metastasis, as presented here, is rare. Autopsy studies of patients with metastatic PCa, show isolated pulmonary metastasis in less than 1% [16] . Fabozzi et al. [17] found radiologic evidence of pulmonary metastases in 48/1,290 patients, with only 11 being a solitary pulmonary nodule (0.86%). In our case, the PSA lowered to non-detection level (< 0.03 µg/l) after resection of the solitary pulmonary metastasis, enabling us to withdraw the hormonal treatment. The PSA still remained undetectable 1 year after withdrawal of the hormonal treatment. Our findings are supported in literature suggesting the benefit of local therapy in patients with low metastatic load [14] [15] [16] .
Conclusion
Solitary pulmonary metastasis of PCa is rare. Chest radiography could be performed in patients with rising PSA after prostatectomy without signs of other visceral or bone metastasis to exclude pulmonary metastasis. Some patients may benefit from surgical resection of the metastatic lesion with excellent PSA-response. Mortier/Baten/Van Renterghem/ Vandeurzen
